IMCR

Immunocore Holdings plc - ADR

33.07

USD

IMCR Earnings Reports

Positive Surprise Ratio

IMCR beat 12 of 20 last estimates.

60%

Next Report

Date of Next Report

Feb 24, 2026

Estimate for Q4 25 (Revenue/ EPS)

$109.68M

-$0.23

Implied change from Q3 25 (Revenue/ EPS)

+5.78%

Implied change from Q4 24 (Revenue/ EPS)

+30.49%

-51.06%

Immunocore Holdings plc - ADR earnings per share and revenue

On Nov 06, 2025, IMCR reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.26 USD, resulting in a 100.00% surprise. Revenue reached 103.69 million, compared to an expected 102.19 million, with a 1.47% difference. The market reacted with a +2.58% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 19 analysts forecast an EPS of -0.23 USD, with revenue projected to reach 109.68 million USD, implying an -- of --% EPS, and increase of 5.78% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

FAQ

What were Immunocore Holdings plc - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Immunocore Holdings plc - ADR reported EPS of $0.00, beating estimates by 100%, and revenue of $103.69M, 1.47% above expectations.

How did the market react to Immunocore Holdings plc - ADR's Q3 2025 earnings?

The stock price moved up 2.58%, changed from $30.80 before the earnings release to $31.59 the day after.

When is Immunocore Holdings plc - ADR expected to report next?

The next earning report is scheduled for Feb 24, 2026.

What are the forecasts for Immunocore Holdings plc - ADR's next earnings report?

Based on 19 analysts, Immunocore Holdings plc - ADR is expected to report EPS of -$0.23 and revenue of $109.68M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.